Gurkamal S Chatta

Roswell Park Cancer Institute · University of Pittsburgh

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official

all conditions, ClinicalTrials.gov

NIH grants tied to them

NIH RePORTER

Trial papers

PubMed author-name match

Trials

Studies that name Gurkamal S Chatta as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:01 UTC. Open this list on ClinicalTrials.gov

Ph1
NCT05037500 · Decitabine/Cedazuridine and Enzalutamide for the Treatment of Metastatic Castrate Resistant Prostate Cancer
Roswell Park Cancer Institute · terminated · Castration-Resistant Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8 · principal investigator
Ph2
NCT03899987 · Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery
Roswell Park Cancer Institute · active not recruiting · Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8 · principal investigator
Ph2
NCT00307294 · Thalidomide and Doxil® in Patients With Androgen Independent Prostate Cancer (AIPC)
University of Pittsburgh · completed · Prostate Cancer · principal investigator
Ph1
NCT00010231 · Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
University of Pittsburgh · completed · Prostate Cancer · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-12 10:01 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

Integrating Cancer and Aging
P20CA103730 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2007 · $618,580 awarded in 2007
Same name and institution; not confirmed by an ID
PH II RNDM DBL BLIND CONTRL'D STDY EVAL SFTY AND EFFICACY PROSTVAC-VF/TRICOM
M01RR000056 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2004 to 2005 · $5,663 awarded in 2005
Same name and institution; not confirmed by an ID
IMMUNOLOGIC THERAPY OF PROSTATE CANCER
R29CA076033 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 1997 to 2001 · $48,320 awarded in 2001
Same name and institution; not confirmed by an ID

Most cited trial papers

Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 10:01 UTC. The ranking covers the 200 most relevant of 13 PubMed records, and a shared surname and initials can bring in a namesake. All 13 on PubMed